ONGLYZA

Onglyza (saxagliptin) is prescribed to treat type 2 diabetes and has been linked to increased risk of heart failure and pancreatic cancer. 2014 NE Journal of Medicine published study of 16,500 Onglyza users -27% were more like to be hospitalized for heart failure than those who did not take the drug . 2013 - FDA warned people taking Onglyza and similar drugs may be more likely to develop pancreatic cancer. 2011- Study in Gastroenterology linked a similar drug to a 2.7 times increased risk of pancreatic cancer.

Free Consultation | Lincoln Dangerous Drug Attorneys

Friedman Law Offices, P.C., L.L.O. is here to help. To schedule a free consultation with our Lincoln, Nebraska dangerous drug attorneys, contact us online in Lincoln, Nebraska, or by calling 866-458-5468 or toll free 888-419-6876.